Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

ThermoGenesis (KOOL) Cord Blood Stem Cell Adaptation in China

Nanshan Memorial Medical Institute (Nanshan) will be utilizing KOOL’s AXP® AutoXpress™ (NYSE:AXP) and BioArchive® Systems used to process and store stem cells from cord blood in its 2 stem cell banks in China.  

The Nanshan facilities are located in Biolake, Wuhan City, a Hubei provincial government supported hi-tech zone specializing in biotechnology and in Jiuzhou Biotechnology Research Park in Xian City, Shanxi Province. Nanshan expects to procure over time the necessary processing and cryopreservation storage capacity to process and store up to several hundred thousand stem cell units at each facility.

  • Nanshan is a progressive regenerative medicine company that distributes medical products and has operated multiple, large healthcare facilities, including hospitals, stem cell banks and research centers.

The Bottom Line: Nanshan’s decision to adopt KOOL’s cord blood technologies follows a 4 year distribution agreement between KOOL and Nanshan signed late last year under which Nanshan will distribute in China and Hong Kong KOOL’s Res-Q™ 60 BMC (Res-Q) System and MXP™ MarrowXpress™ products used to prepare cell concentrates, including stem cells from bone marrow at the point-of-care and in the laboratory. KOOL’s AXP is proven technology for the precise isolation and high yield of stem cells in a quick and efficient process, while the BioArchive represents state-of-the-art storage technology for preserving the viability of stem cells from cord blood.